EpiPen Price Gouge CEO: Daughter Of A Democratic Senator And A Clinton Foundation Donor

While outrage continues over the rapid price incread of the life-saving EpiPen–an act some are calling price-gouging–we’ve learned that the company responsible for the increase, Mylan Pharmaceuticals, is a Clinton Foundation donor helmed by the daughter of a Democratic Senator.

Mylan Pharmaceuticals CEO Heather Bresch, daughter of West Virginia Senator Joe Manchin, is being criticized for Mylan’s 400% increase in the price of the epinephrine auto-injector over a short period of time. The increase has led retailers to charge up to $600 for the device, which cost closer to $100 when Mylan acquired it from Merck in 2008.

Senator Minchin was an early supporter of Clinton, having officially endorsed her in April of 2015.

Mylan CEO Bresch reportedly earned a salary of close to $19 million in 2015, an increase in 671% over the same period in which the EpiPen rose in price.

In addition, Mylan has contributed up to $250,000 to the Clinton Foundation according to the foundation’s records.

Despite the connections to Clinton, the Democratic nominee has been critical of Mylan Pharmaceuticals actions. “That’s outrageous – and it’s just the latest troubling example of a company taking advantage of its consumers,” Clinton said in a statement. “I believe that our pharmaceutical and biotech industries can be an incredible source of American innovation, giving us revolutionary treatments for debilitating diseases.”

If you haven’t checked out and liked our Facebook page, please go here and do so.

Leave a comment...